BackCan-Fite Biopharma Overview
Can-Fite Biopharma Ltd - ADR

Can-Fite Biopharma Target Price

Analysts' 12-month price predictions for CANF.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.99

Average Target Price

$5.0067.2% upside

1 analysts in the last 4 months

High: $5 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-12H.C. WainwrightSwayampakula Ramakanth$567.2% upsideOpen
2025-04-15Industrial Alliance SecuritiesJames Molloy$902910% upsideOpen
2024-07-17EF HuttonJason Kolbert$2006589% upsideOpen